FinnCap reaffirmed their corporate rating on shares of Cambridge Cognition Holdings PLC (LON:COG) in a report published on Thursday. FinnCap currently has a GBX 115 ($1.50) target price on the stock.

Shares of Cambridge Cognition Holdings PLC (LON:COG) traded down 1.07% during midday trading on Thursday, reaching GBX 83.60. 36,491 shares of the company traded hands. Cambridge Cognition Holdings PLC has a 12 month low of GBX 30.00 and a 12 month high of GBX 105.00. The firm’s market capitalization is GBX 15.59 million. The company has a 50 day moving average of GBX 62.22 and a 200 day moving average of GBX 45.55.

Cambridge Cognition Holdings PLC Company Profile

Cambridge Cognition Holdings plc is a holding company. The Company operates through its wholly owned subsidiary, Cambridge Cognition Limited (CCL). It develops and commercializes computerized neuropsychological tests for sale, principally in the United Kingdom, the United States and Europe. The Company has three segments: Healthcare, which includes medical software for use in healthcare delivery settings; Academic Research, which includes cognitive test products for researchers working in a non-regulated environment, and Clinical Trials, which includes products and services for use in regulated pharmaceutical clinical trials.

Receive News & Stock Ratings for Cambridge Cognition Holdings PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition Holdings PLC and related stocks with our FREE daily email newsletter.